Integra Lifesciences HLD (iart 0.5 08/15/25)
13F holders, Q1 2025 (March 31)1holders −1
0new positions
1sold out
$0.98avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Integra Lifesciences HLD (iart 0.5 08/15/25) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holder was BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.9M).
- Company
- Integra Lifesciences HLD (iart 0.5 08/15/25)
- CUSIP
- 457985AM1
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $2.3M |
All 13F filers, Q4 2024 → Q1 2025: 2,500,000 shares sold, net −2,500,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 3,000,000 | $2.9M |
"% of holder's portfolio" is INTEGRA LIFESCIENCES HLD (IART 0.5 08/15/25)'s weight in each manager's 13F, not the share of Integra Lifesciences HLD (iart 0.5 08/15/25) the manager owns.